IJMS | Free Full-Text | Effects of Anti-Calcitonin Gene-Related Peptide for Migraines: A Systematic Review with Meta-Analysis of Randomized Clinical Trials
Novartis data confirm long-term efficacy and safety of Aimovig® for majority of patients with episodic migraine | Novartis
Frontiers | Assessment of the Effect of Erenumab on Efficacy and Quality-of-Life Parameters in a Cohort of Migraine Patients With Treatment Failure in Cyprus
Erenumab: First-in-Class Approved for Migraine Prevention
Aimovig® (erenumab-aooe) for the Preventive Treatment of Migraine in Adults
Erenumab for the Prevention of Migraine, Including the Rationale, Findings and Clinical Implications of the LIBERTY Study - touchNEUROLOGY
A Controlled Trial of Erenumab for Episodic Migraine | NEJM
Optimal treatment strategy of fremanezumab in migraine prevention: a systematic review with network meta-analysis of randomized clinical trials | Scientific Reports
Post hoc analysis of clinical trial data and pharmacokinetic data to assess wearing‐off of erenumab within monthly treatment cycle - Dodick - Headache: The Journal of Head and Face Pain - Wiley
A Controlled Trial of Erenumab for Episodic Migraine ... | GrepMed
Efficacy and tolerability of erenumab in patients with episodic migraine in whom two-to-four previous preventive treatments were unsuccessful: a randomised, double-blind, placebo-controlled, phase 3b study - The Lancet
Pooled retrospective analysis of 70 mg erenumab in episodic and chronic migraine: a two tertiary headache centers experience during clinical practice | SpringerLink
A Controlled Trial of Erenumab for Episodic Migraine | NEJM
Migraine prevention with erenumab | TCRM
Efficacy and tolerability of erenumab in patients with episodic migraine in whom two-to-four previous preventive treatments were unsuccessful: a randomised, double-blind, placebo-controlled, phase 3b study - The Lancet
![PDF] ARISE: A Phase 3 randomized trial of erenumab for episodic migraine | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/57b8c7a7cd9246b7072730224457f3a70d5b4e82/5-Table2-1.png "PDF] ARISE: A Phase 3 randomized trial of erenumab for episodic migraine | Semantic Scholar")
PDF] ARISE: A Phase 3 randomized trial of erenumab for episodic migraine | Semantic Scholar
Novartis data show Aimovig® cuts acute migraine medication days by half in patients who failed prior preventive therapies | Novartis
Long‐term efficacy and safety of erenumab in migraine prevention: Results from a 5‐year, open‐label treatment phase of a randomized clinical trial - Ashina - 2021 - European Journal of Neurology - Wiley Online Library
The appropriate dosing of erenumab for migraine prevention after multiple preventive treatment failures: a critical appraisal | The Journal of Headache and Pain | Full Text
Novartis announces positive results from a Phase IV study showing superior tolerability and efficacy of Aimovig® (erenumab) compared with topiramate in migraine prevention | Novartis
Aimovig (erenumab) for the Treatment of Episodic Migraine
![PDF] Efficacy and tolerability of erenumab in patients with episodic migraine in whom two-to-four previous preventive treatments were unsuccessful: a randomised, double-blind, placebo-controlled, phase 3b study | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/2b5d2470ef97a1399bd34d281f9f37ddf42e79f0/4-Figure1-1.png "PDF] Efficacy and tolerability of erenumab in patients with episodic migraine in whom two-to-four previous preventive treatments were unsuccessful: a randomised, double-blind, placebo-controlled, phase 3b study | Semantic Scholar")
PDF] Efficacy and tolerability of erenumab in patients with episodic migraine in whom two-to-four previous preventive treatments were unsuccessful: a randomised, double-blind, placebo-controlled, phase 3b study | Semantic Scholar
Randomised, controlled trial of erenumab for the prevention of episodic migraine in patients from Asia, the Middle East, and Latin America: The EMPOwER study - Shuu-Jiun Wang, Artemio A Roxas, Bibiana Saravia,
